"Anthrax" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An acute infection caused by the spore-forming bacteria BACILLUS ANTHRACIS. It commonly affects hoofed animals such as sheep and goats. Infection in humans often involves the skin (cutaneous anthrax), the lungs (inhalation anthrax), or the gastrointestinal tract. Anthrax is not contagious and can be treated with antibiotics.
Descriptor ID |
D000881
|
MeSH Number(s) |
C01.252.410.090.072
|
Concept/Terms |
Anthrax- Anthrax
- Bacillus anthracis Infection
- Bacillus anthracis Infections
|
Below are MeSH descriptors whose meaning is more general than "Anthrax".
Below are MeSH descriptors whose meaning is more specific than "Anthrax".
This graph shows the total number of publications written about "Anthrax" by people in this website by year, and whether "Anthrax" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 1 | 2 | 3 |
2003 | 1 | 1 | 2 |
2004 | 1 | 0 | 1 |
2005 | 0 | 1 | 1 |
2006 | 0 | 1 | 1 |
2007 | 1 | 0 | 1 |
2009 | 0 | 1 | 1 |
2011 | 1 | 0 | 1 |
2012 | 1 | 0 | 1 |
2013 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anthrax" by people in Profiles.
-
Franks SE, Ebrahimi C, Hollands A, Okumura CY, Aroian RV, Nizet V, McGillivray SM. Novel role for the yceGH tellurite resistance genes in the pathogenesis of Bacillus anthracis. Infect Immun. 2014 Mar; 82(3):1132-40.
-
Anderson PD, Bokor G. Bioterrorism: pathogens as weapons. J Pharm Pract. 2012 Oct; 25(5):521-9.
-
Artenstein AW, Opal SM. Novel approaches to the treatment of systemic anthrax. Clin Infect Dis. 2012 Apr; 54(8):1148-61.
-
Opal SM, Lim YP, Cristofaro P, Artenstein AW, Kessimian N, Delsesto D, Parejo N, Palardy JE, Siryaporn E. Inter-a inhibitor proteins: a novel therapeutic strategy for experimental anthrax infection. Shock. 2011 Jan; 35(1):42-4.
-
McGillivray SM, Ebrahimi CM, Fisher N, Sabet M, Zhang DX, Chen Y, Haste NM, Aroian RV, Gallo RL, Guiney DG, Friedlander AM, Koehler TM, Nizet V. ClpX contributes to innate defense peptide resistance and virulence phenotypes of Bacillus anthracis. J Innate Immun. 2009; 1(5):494-506.
-
Kim C, Wilcox-Adelman S, Sano Y, Tang WJ, Collier RJ, Park JM. Antiinflammatory cAMP signaling and cell migration genes co-opted by the anthrax bacillus. Proc Natl Acad Sci U S A. 2008 Apr 22; 105(16):6150-5.
-
Artenstein AW. Anthrax: from antiquity to answers. J Infect Dis. 2007 Feb 15; 195(4):471-3.
-
Agin JR, Ziemer WA, Newman MC, Guilfoyle DE, Vought K, Ledenbach L, Brodsky MH, Hill W, Rice D, Ferreira JL, Werner BG, Martin BM, Shively R, Marrow T, Phillips RW, Wehling P, Labudde RA. Committee on microbiology and extraneous materials. J AOAC Int. 2006 Nov-Dec; 89(6):1700-1.
-
Opal SM, Artenstein AW, Cristofaro PA, Jhung JW, Palardy JE, Parejo NA, Lim YP. Inter-alpha-inhibitor proteins are endogenous furin inhibitors and provide protection against experimental anthrax intoxication. Infect Immun. 2005 Aug; 73(8):5101-5.
-
Artenstein AW, Opal SM, Cristofaro P, Palardy JE, Parejo NA, Green MD, Jhung JW. Chloroquine enhances survival in Bacillus anthracis intoxication. J Infect Dis. 2004 Nov 01; 190(9):1655-60.